These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 32503897)
1. Neurotoxicity-CAR T-cell therapy: what the neurologist needs to know. Neill L; Rees J; Roddie C Pract Neurol; 2020 Aug; 20(4):285-293. PubMed ID: 32503897 [TBL] [Abstract][Full Text] [Related]
2. Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell Therapy. Smith DA; Kikano E; Tirumani SH; de Lima M; Caimi P; Ramaiya NH Radiology; 2022 Feb; 302(2):438-445. PubMed ID: 34751616 [TBL] [Abstract][Full Text] [Related]
3. Current and emerging pharmacotherapies for cytokine release syndrome, neurotoxicity, and hemophagocytic lymphohistiocytosis-like syndrome due to CAR T cell therapy. Walton ZE; Frigault MJ; Maus MV Expert Opin Pharmacother; 2024 Feb; 25(3):263-279. PubMed ID: 38588525 [TBL] [Abstract][Full Text] [Related]
4. A Concise Review of Neurologic Complications Associated with Chimeric Antigen Receptor T-cell Immunotherapy. Ruff MW; Siegler EL; Kenderian SS Neurol Clin; 2020 Nov; 38(4):953-963. PubMed ID: 33040871 [TBL] [Abstract][Full Text] [Related]
5. Clinical Presentation, Risk Factors, and Outcomes of Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T Cell Therapy: A Systematic Review. Grant SJ; Grimshaw AA; Silberstein J; Murdaugh D; Wildes TM; Rosko AE; Giri S Transplant Cell Ther; 2022 Jun; 28(6):294-302. PubMed ID: 35288347 [TBL] [Abstract][Full Text] [Related]
6. Neurological Complications of CAR T Cell Therapy. Landry K; Thomas AA Curr Oncol Rep; 2020 Jul; 22(8):83. PubMed ID: 32607727 [TBL] [Abstract][Full Text] [Related]
13. Neurological updates: neurological complications of CAR-T therapy. Tallantyre EC; Evans NA; Parry-Jones J; Morgan MPG; Jones CH; Ingram W J Neurol; 2021 Apr; 268(4):1544-1554. PubMed ID: 33140239 [TBL] [Abstract][Full Text] [Related]
14. CAR-T Cell Therapy-Related Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia: Spectrum of Imaging Findings. Tan AP Pediatr Neurol; 2020 Oct; 111():51-58. PubMed ID: 32951662 [TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells. Karschnia P; Arrillaga-Romany IC; Eichler A; Forst DA; Gerstner E; Jordan JT; Ly I; Plotkin SR; Wang N; Martinez-Lage M; Winter SF; Tonn JC; Rejeski K; von Baumgarten L; Cahill DP; Nahed BV; Shankar GM; Abramson JS; Barnes JA; El-Jawahri A; Hochberg EP; Johnson PC; Soumerai JD; Takvorian RW; Chen YB; Frigault MJ; Dietrich J Neuro Oncol; 2023 Dec; 25(12):2239-2249. PubMed ID: 37402650 [TBL] [Abstract][Full Text] [Related]
16. Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma. Nie EH; Ahmadian SS; Bharadwaj SN; Acosta-Alvarez L; Threlkeld ZD; Frank MJ; Miklos DB; Monje M; Scott BJ; Vogel H J Neuropathol Exp Neurol; 2023 Jan; 82(2):160-168. PubMed ID: 36592076 [TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies. Siegler EL; Kenderian SS Front Immunol; 2020; 11():1973. PubMed ID: 32983132 [TBL] [Abstract][Full Text] [Related]
18. Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy. Lapidus AH; Anderson MA; Harrison SJ; Dickinson M; Kalincik T; Lasocki A Leuk Lymphoma; 2022 Oct; 63(10):2364-2374. PubMed ID: 35570737 [TBL] [Abstract][Full Text] [Related]
19. Cytokine release syndrome and neurotoxicity following CAR T-cell therapy for hematologic malignancies. Freyer CW; Porter DL J Allergy Clin Immunol; 2020 Nov; 146(5):940-948. PubMed ID: 32771558 [TBL] [Abstract][Full Text] [Related]
20. Severe persistent neurotoxicity associated with CAR T therapy in children. Andrew EC; Hughes D; Gilsenan M; Mignone C; Khaw SL; Wang SS Br J Haematol; 2023 Nov; 203(4):651-655. PubMed ID: 37528536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]